![]() |
市场调查报告书
商品编码
1892860
光学相干断层扫描市场机会、成长驱动因素、产业趋势分析及预测(2025-2034年)Optical Coherence Tomography Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球光学相干断层扫描市场价值为 18 亿美元,预计到 2034 年将以 10.2% 的复合年增长率成长至 48 亿美元。

光学相干断层扫描(OCT)是一种非侵入性成像方法,它利用低相干光产生生物组织的高解析度横断面影像。随着研发工作的加速,旨在提高诊断清晰度、增加组织探测深度和加快影像撷取速度的技术不断涌现,市场持续成长。这些进步推动了下一代诊断工具和治疗监测系统在各种临床环境中的应用。对小型便携式OCT设备的需求不断增长,也影响OCT的发展趋势,尤其是在医疗机构寻求便利的即时检测解决方案,以服务乡村诊所、流动诊所、家庭护理机构和门诊中心等场所时。对行动性和工作流程效率的日益重视,促使製造商推出更精简、用户友好的成像系统,以适应更广泛的临床应用。早期检测策略在眼部疾病诊断的应用日益广泛,进一步增强了现代眼科护理对OCT技术的依赖。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 18亿美元 |
| 预测值 | 48亿美元 |
| 复合年增长率 | 10.2% |
2024年,光谱域光学相干断层扫描(SD-OCT)市占率达76%。该细分市场占据领先地位,主要原因是影响视网膜健康的慢性眼部疾病发病率不断上升,从而推动了对精准、快速、高解析度成像的需求。 SD-OCT设备不仅常用于视网膜成像,也常用于评估眼前节、角膜状况和视神经。其适应性强,可用于从疾病分期到治疗后评估等各种临床应用,使其成为全面视力评估中不可或缺的一部分。
2024年,桌上型OCT设备市占率达到74.6%。这些系统仍然是眼科专业人士的首选,因为它们能够提供稳定、高精度的成像,并与多种扫描技术相容。它们在眼科中心、专科机构和医院科室的广泛应用,得益于其能够辅助分析青光眼进展、视网膜疾病和眼前节健康状况。现代桌上型设备通常将多种成像技术整合于单一平台,从而打造高效的诊断工作站。
美国光学相干断层扫描(OCT)市场预计在2024年达到6.31亿美元,并在2034年达到16亿美元。联邦医疗保险(Medicare)和私人保险公司对OCT相关检查的广泛覆盖,降低了患者和医疗机构的成本,从而促进了市场普及。 OCT的报销范围涵盖多种应用,包括视神经分析、视网膜扫描和OCT血管造影,这鼓励眼科诊所将OCT更常规地整合到临床工作流程中。
The Global Optical Coherence Tomography Market was valued at USD 1.8 billion in 2024 and is estimated to grow at a CAGR of 10.2% to reach USD 4.8 billion by 2034.

OCT is a non-invasive imaging method that uses low-coherence light to produce highly detailed cross-sectional visuals of biological tissues. The market continues to grow as research and development efforts accelerate the launch of technologies aimed at improving diagnostic clarity, increasing tissue-depth reach, and speeding image acquisition. These advancements support the introduction of next-generation diagnostic tools and therapy-monitoring systems across various clinical environments. Rising demand for compact and portable OCT devices is also influencing development trends, especially as healthcare providers seek accessible solutions for point-of-care testing across rural practices, traveling clinics, home care facilities, and outpatient centers. The growing shift toward mobility and workflow efficiency is encouraging manufacturers to introduce more streamlined and user-friendly imaging systems designed for broader clinical use. Increasing adoption of early-detection strategies for major eye diseases further strengthens the reliance on OCT technology in modern ophthalmic care.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $1.8 Billion |
| Forecast Value | $4.8 Billion |
| CAGR | 10.2% |
The spectral domain OCT segment accounted for a 76% share in 2024. This segment holds a leading position due to rising incidences of chronic eye disorders that impact retinal health and drive the need for precise, fast, and high-resolution imaging. SD-OCT devices are frequently used not only for retinal interpretation but also for assessing the anterior segment, corneal conditions, and the optic nerve. Their adaptability for various clinical tasks, from disease staging to post-treatment evaluations, makes them integral to comprehensive vision assessment.
The tabletop OCT equipment segment held a 74.6% share in 2024. These systems remain the preferred choice for ophthalmic professionals because they offer stable, highly accurate imaging and compatibility with multiple scanning techniques. Their widespread use in eye centers, specialty facilities, and hospital departments is supported by their ability to assist in analyzing glaucoma progression, retinal disorders, and anterior segment health. Modern tabletop devices often combine multiple imaging technologies into a single platform, creating efficient diagnostic workstations.
United States Optical Coherence Tomography Market is projected to reach USD 631 million in 2024 and reach USD 1.6 billion by 2034. Substantial coverage from Medicare and private payers for OCT-related procedures enhances market adoption by lowering costs for both patients and providers. Reimbursement applies to several applications, including optic nerve analysis, retinal scanning, and OCT angiography, which encourages eye care practices to integrate OCT more routinely into clinical workflows.
Key companies participating in the Optical Coherence Tomography Market include Abbott Laboratories, Canon, Agfa-Gevaert, Gentuity, Huvitz, Heidelberg Engineering, Carl Zeiss Meditec, NIDEK, Metall Zug AG (Haag-Streit Group), Moptim (Shenzhen Certainn Technology), Nikon Corporation (Optos plc), Philophos, NotaLVision, NinePoint Medical, Novacam Technologies, OPTOPOL Technology, Topcon Corporation, Tomey, TowardPi (Beijing) Medical Technology, Visionx, Vivolight, YSENMED, and ZD Medical. Key strategies employed by major companies in the Optical Coherence Tomography Market focus on enhancing imaging performance, broadening clinical applications, and expanding product accessibility. Firms continue to invest in advanced light-source technologies and upgraded scanning algorithms to deliver sharper resolution and faster image capture. Many players are integrating multimodal imaging into unified systems to streamline diagnostic processes for clinicians. Collaborations with healthcare providers and academic research centers help refine device accuracy and support clinical validation.